市场调查报告书
商品编码
1284251
到 2028 年的白色生物技术市场预测 - 按产品(生物聚合物、生物燃料、其他产品)、最终用户(电子和半导体、消费品和服务、其他最终用户)、地区分列的全球分析White Biotech Market Forecasts to 2028 - Global Analysis By Product (Biopolymers, Biofuels and Other Products), End User (Electronics and Semiconductor, Consumer Goods And Services and Other End Users) and By Geography |
根据Stratistics MRC,2022年全球白色生物技术市场规模将达到2053.8亿美元,预计到2028年将达到4321.5亿美元,预计年復合增长率为13.2%
科学技术思想的应用构成了生物技术的基础。 工业生物技术是白色生物技术的别称。 一种利用□和微生物生产生物基产品的方法,可用于多种行业,包括化学品、生物能源、家庭护理、食品和饲料以及製药。 新兴国家和贫穷国家的最终用户基本上没有意识到白色生物技术产品给他们的日常生活带来的好处以及非生物产品温室气体排放的负面影响。
根据总部位于法国的政府间组织国际能源署 (IEA) 分享的一份报告,到 2022 年,全球将生产 450 亿升生物柴油,高于 2020 年的 370 亿升。
在过去的几年里,人们对白色生物技术的应用及其诸多好处有了更好的了解,例如环保、降低製造成本、产生更少的废物以及最大限度地利用原材料。来自最终用户的需求在成长。 消费者对绿色化学品的高需求,尤其是在发达国家,迫使製造商采用白色生物技术而不是传统的化学生产工艺。 此外,近年来,聚合物生产技术的开发,尤其是生物质生产技术的开发,为生化市场创造了有利可图的机会。
人口增长、农业用地稀缺、土地持有量小以及土壤肥力下降等因素会迅速侵蚀生物作物的生产。 对农作物滥用或不正确施肥也在消耗农田的肥力,耗尽其肥力。 生物作物的价格也因化肥的过度使用而波动,因为产量的不确定性预计将限制市场扩张。 大多数养分目前的养分利用效率仍然很低。 因此,土地肥力下降和生物作物生产受限可能会限制预测期内的市场增长。
全球对生物基和可生物降解聚合物的需求量达到 96 万吨。 儘管仍处于起步阶段,生物塑料行业已成为许多商业行业和应用的基石。 消费者对环保材料的偏好、塑料加工商和復合商对生物塑料的使用增加以及扩大生物塑料优势的新产品发布预计将推动几乎所有地区的需求强劲增长。
由于与传统肥料相比,发达经济体和新兴经济体对生物肥料的采用率较低,预计全球白色生物技术市场的增长将放缓。 土壤肥力下降和粮食需求增加正在增加对常规肥料的需求。 此外,与传统燃料相比,生物燃料的采用率较低,预计也将抑制市场扩张。 这是由于生物燃料的不稳定供应以及传统燃料优于生物燃料的性能。
COVID-19 大流行对白色生物技术市场的製药行业创新产生了重大影响,表明该领域的市场扩张取得了成功。 消费者对绿色化学品的需求不断增长,尤其是在北美和欧洲等发达地区,预计将推动製造商使用白色生物技术工艺代替传统化学品製造。 在预测期内,随着汽车和消费品行业等各种消费行业在实现其可持续发展目标方面面临越来越大的压力,预计对技术的需求将会增加。
由于更严格的立法、环境问题和客户对更可持续产品的需求,生化行业预计将实现利润丰厚的增长。 因此,多年来,包括家用清洁剂製造商在内的清洁剂製造商通过降低温度、减少包装和增加拟议产品中生物基成分的数量来减少碳足迹。
由于在生物製药生产中越来越多地使用技术,尤其是不能通过化学合成製造的用于癌症治疗的抗体,预计医疗保健行业在预测期内将以最快的复合年增长率增长。 此外,该方法中使用的□能够製备难以合成的手性分子和中间体,例如活性药物成分 (API)。
由于生物技术增强型食品配料的可用性,预计亚太地区在预测期内将占据最大的市场份额。 在这种技术中,玩家为他们附近的企业提供资金。 它还限制了中国生物技术和製药行业的发展,因为产品污染会改变效力并降低产品质量。
预计北美在预测期内的复合年增长率最高。 随着人类和牲畜数量的增长,对食物的需求也在增长。 城市侵占农业用地给土地利用带来压力。 这种国际趋势为生物技术促进农业生产提供了机会。
2022 年 3 月,爱尔兰上市食品公司 Kerry Group plc 将以 1.348 亿美元(1.37 亿欧元)的价格收购 c-Lecta 92% 的已发行股本。 此次收购将加速凯爱瑞在□工程、发酵和生物工艺开发方面的创新能力。
2021 年 3 月,巴斯夫风险投资公司 (BVC) 投资了位于中国杭州的工业合成生物技术公司 Bota Biosciences Ltd。 该公司开发了下一代生物技术平台,能够以可持续和经济的方式生产高价值产品,用于广泛的工业应用,包括甜味剂、维生素、个人护理和农药保护产品。
According to Stratistics MRC, the Global White Biotech Market is accounted for $205.38 billion in 2022 and is expected to reach $432.15 billion by 2028 growing at a CAGR of 13.2% during the forecast period. The use of scientific and technical ideas forms the foundation of biotechnology. Industrial biotechnology is another name for white biotechnology. In order to produce bio-based products that may be used in a variety of industries, including chemicals, bio-energy, home care, food and feed, and pharmaceuticals, this method makes use of enzymes and microorganisms. The advantages of white biotech products in everyday life and the negative consequences of greenhouse gas emissions from non-biological products are not commonly known to end users in emerging and impoverished nations.
According to a report shared by the International Energy Agency (IEA), a France-based autonomous intergovernmental organization, by 2022, 45 billion liters of biodiesel will be produced worldwide, up from 37 billion in 2020.
White biotechnology has seen a growth in demand from end users over the past few years as a result of a growing understanding of its uses and numerous benefits, which include eco-friendliness, reduced manufacturing costs, little waste formation, and maximum raw material utilisation. Consumer demand for green chemicals, especially in developed nations, is forcing manufacturers to adopt white biotechnology rather than conventional chemical production processes. Furthermore, the development of polymer production technology, notably from biomass, has created profitable opportunities in the biochemical market over the past few years.
The production status of bio crops may soon be lost due to factors such as the growing population, the scarcity of agricultural land, small landholdings, and declining soil fertility. The fertility of agricultural areas also decreased due to the misuse and incorrect application of fertilisers to crops, which has led to the depletion of that fertility. Because there is uncertainty over the production yield, which is expected to restrict market expansion, the prices of bio-crops have also fluctuated due to excessive fertiliser use. The current degree of nutrient-use efficiency is still quite low for the majority of nutrients. As a result, falling land fertility is limiting the production of bio crops, which could restrict the market's growth throughout the projection period.
Global demand for bio-based and biodegradable polymers reached 960,000 metric tonnes. The bioplastics industry, though still in its infancy, has established itself as a cornerstone in a number of commercial industries and applications. Due to consumer preferences for eco-friendly materials, a growth in the usage of bioplastics by plastic processors and compounders, and the launch of new products that expand the benefits of bioplastics, demand is anticipated to rise significantly in almost all geographic areas.
The global white biotechnology market is anticipated to experience slower growth due to lower adoption of biofertilizers compared to traditional fertilisers in both developed and emerging economies. Increased desire for conventional fertilisers is a result of declining soil fertility and growing food demand. Additionally, it is anticipated that lesser adoption of biofuels relative to conventional fuels will also restrain market expansion. This is caused by the variable supply of biofuels and the superior performance of conventional fuels over biofuels.
The COVID-19 pandemic had a huge impact on the pharmaceutical industry's innovation in the white biotechnology market, which suggests a successful market expansion in the sector. The growing consumer demand for green chemicals, particularly in developed regions like North America and Europe, is expected to drive manufacturers to use white biotechnology processes rather than conventional chemical manufacturing. Over the projection period, it is anticipated that the demand for technology would increase due to the growing pressure on various consumer industries, such as the automotive and consumer goods sectors, to fulfil the sustainability targets.
The biochemicals segment is estimated to have a lucrative growth, as a result of stricter laws, environmental concerns, and customer demand for more sustainable products. As a result, producers of cleaning products including those for the home have been decreasing their carbon footprints for years by lowering suggested product temperatures, reducing packaging, and increasing the number of bio-based components.
The healthcare segment is anticipated to witness the fastest CAGR growth during the forecast period, due to increasing technological use in the production of biopharmaceuticals, particularly antibodies for cancer treatment that cannot be produced through chemical synthesis. Additionally, the creation of chiral molecules and other challenging-to-synthesize intermediates, including active pharmaceutical ingredients (API), is made possible by the enzymes used in this method.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the availability of biotechnologically altered food ingredients. In this approach, players contribute money to nearby companies. Additionally, product contamination results in variable potency and poor product quality, which restrict the growth of the Chinese biotech and pharmaceutical industry.
North America is projected to have the highest CAGR over the forecast period. Food demand is rising due to an increase in both human and livestock populations. As urban areas are encroaching on agricultural grounds, it puts pressure on how land is used. These international trends provide biotechnology with the opportunity to boost agricultural production.
Some of the key players profiled in the White Biotech Market include Global Bioenergies, Solazyme, Borregaard, BioAmber., Fermentalg, Amyris, Codexis, Deinove, Novozymes, Metabolic Explorer, Evolva, Gevo, Kerry Group plc and BASF SE.
In March 2022, Kerry Group plc (Kerry), an Ireland-based public food company, acquired 92% of the issued share capital of c-Lecta for $134.8 million (€ 137M). With this acquisition, Kerry's innovative capabilities in enzyme engineering, fermentation, and bioprocess development will be accelerated.
In March 2021, BASF Venture Capital (BVC) invested in Bota Biosciences Ltd (Bota Bio), an industrial synthetic biotech company located in Hangzhou, China, which develops next-generation biotechnology platforms, enabling sustainable and economical production of high-value products for a broad array of industrial applications, like sweeteners, vitamins, personal care, or crop protection products.